ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Can Autoimmune Conditions be Reversed? Researchers Make a Surprising Discovery

Scientifically-designed fasting diet lowers risks for major diseases

How One Tiny Molecule Turned into One Huge Health Breakthrough

Acupuncture boosts effectiveness of standard medical care for chronic pain, depression

Research on Astaxanthin Demonstrates Significant Whole Body Benefits

Humans have three times more brown body fat

Nutrients Boost Stem Cell Function

B12 Proven Essential for Every Cell

Soy isoflavones may benefit breast cancer patients

Dietary prebiotics improve sleep, buffer impacts of stress, says study

 
Print Page
Email Article

New Data Projects Alzheimer's Disease Could Affect 16 Million by 2050

  [ 107 votes ]   [ Discuss This Article ]
www.ProHealth.com • July 26, 2002


New research released at the 8th International Conference on Alzheimer's Disease and Related Disorders, indicates that the prevalence of the disease in the United States will increase from 4.5 million in 2000 to between 11 and 16 million by the year 2050.

The study, conducted by Denis A. Evans, M.D., of the Rush Institute on Healthy Aging and the Rush Alzheimer's Disease Center in Chicago, bases its findings on figures from the Chicago Health and Aging Project, a large study supported by the National Institutes of Health, and population figures from the 2000 U.S. Census.

Projections from this study are consistent with, though slightly higher than, projections from a similar study using 1990 U.S. Census data conducted by Evans 10 years ago.

The Alzheimer's disease incidence data represent a population-based study of 6,158 persons and projects low, middle and high estimates of people with the disease in three age categories: 65-74, 75-84, and 85+. The study's findings show little change in the youngest age group, but significant increases in the two older groups.

Evans attributes the surge in the two older age groups to the size of the population moving into the age for Alzheimer onset within the next 10 years and the life span of that population extending beyond 85 years of age.

"The study shows growth in the current Alzheimer population over the next 50 years, with the most significant surge in the 85 and older age group, or the oldest of the old," Evans said.

According to Alzheimer's Disease International, there are 18 million people worldwide with dementia. The World Health Reports 2001, from the World Health Organization, estimated that there may be as many as 37 million people worldwide with dementia.

It is estimated that costs for treating Alzheimer's disease in the U.S. alone are at least $100 billion annually. A study released last month estimated the cost to U.S. businesses - in lost productivity and absenteeism of employees who care for family members with Alzheimer's disease - to be $61 billion a year.

Alzheimer's Association Interim President and CEO Stephen McConnell, Ph.D., warned of the ramifications for health care systems around the world and cited the scope of research on the cost of Alzheimer's being presented at the conference as further evidence that Alzheimer's is a looming global crisis.

"The study on Alzheimer prevalence and those on the costs related to Alzheimer's underscore the urgent need for more research into the causes, prevention and treatment of this devastating disease," McConnell said. "We must find the answers before these projections become a reality. That's why in the United States the Alzheimer's Association is urging the U.S. Congress to increase federal funding of Alzheimer research to $1 billion."



Post a Comment

Featured Products From the ProHealth Store
Vitamin D3 Extreme™ Ultra ATP+, Double Strength Mitochondria Ignite™ with NT Factor®

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid

Natural Remedies

Olea25 Olive Hydroxytyrosol Hits Astonishing 68,000+ ORAC Antioxidant Value Olea25 Olive Hydroxytyrosol Hits Astonishing 68,000+ ORAC Antioxidant Value
Are You Obtaining the Proper Enzymes? Are You Obtaining the Proper Enzymes?
"It's Not Easy Being Green" - But It Is Healthy
The Crucial Role CoQ10 Plays in Fibromyalgia and ME/CFS The Crucial Role CoQ10 Plays in Fibromyalgia and ME/CFS
Breaking Through the Mental Fog Breaking Through the Mental Fog

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map